Research programme: selectin-binding and selectin ligand metabolic inhibitors - TumorEnd
Latest Information Update: 28 Aug 2020
Price :
$50 *
At a glance
- Originator TumorEnd
- Class Small molecules
- Mechanism of Action E-selectin inhibitors; L-selectin inhibitors; P selectin inhibitors; Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Inflammation in USA
- 19 Jul 2016 Early research in Inflammation in USA (unspecified route)